STEPHEN HUNT to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications STEPHEN HUNT has written about Xenograft Model Antitumor Assays.
Connection Strength
0.043
-
Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma. Mol Cancer Ther. 2024 12 03; 23(12):1815-1826.
Score: 0.043